Sandy Liebhard

Sandy A. Liebhard, a founding partner at Bernstein Liebhard LLP, has successfully represented plaintiffs in complex litigations for more than 20 years. As dedicated consumer advocates, Mr. Liebhard and his fellow attorneys have taken on some of the largest corporate interest in the nation in cases involving dangerous pharmaceuticals, faulty medical devices and defective consumer products. As an author for RXInuryHelp.com, Mr. Liebhard has written extensively on the litigation involving proton pump inhibitors (Nexium, Prilosec, PrevAcid, etc.) and kidney injuries; Risperdal and gynecomastia; the Bair Hugger forced air warming blanket; talcum powder and ovarian cancer; transvaginal mesh; power morcellators; defective hip implants; and more.

Mr. Liebhard is a 1988 graduate of Brooklyn Law School. He is admitted to the Bar of the State of New York, as well as the United States District Courts for the Southern and Eastern Districts of New York.


AndroGel Lawsuit Parties Propose Bellwether Trial Candidates

The federal testosterone litigation continues to wrestle with the selection of cases for the proceeding’s first bellwether trials. Earlier this week, the parties involved in the massive multidistrict litigation each identified a number of AndroGel lawsuits as bellwether candidates. However, … Continue reading

Parties to New Jersey Talcum Powder Lawsuit Reach Agreement on Tissue Testing

Hundreds of talcum powder lawsuits filed against Johnson & Johnson continue to move forward in courts around the country. Earlier this month, the parties to a case pending in New Jersey federal court indicated that they had been able to … Continue reading

Taxotere Lawsuit Plaintiffs Propose Multidistrict Litigation for Federal Hair Loss Cases

Plaintiffs pursuing Taxotere lawsuits over the chemotherapy drug’s alleged association with permanent alopecia have asked a panel of federal judges to consolidate their claims in a single U.S. District Court. In a Motion for Transfer filed with the U.S. Judicial … Continue reading

Levaquin Label Updated With New Black Box Warning

Federal drug regulators announced yesterday that the labels for Levaquin and other fluoroquinolone antibiotics have been updated with new information regarding their potential to cause a wide array of debilitating side effects.   All drugs in the class, including Levaquin, Cipro, … Continue reading

Risperdal Trial Judge Rejects Bid to Overturn $70 Million Verdict

The Pennsylvania judge who presided over the most recent Risperdal lawsuit trial has rejected Janssen Pharmaceutical’s bid to overturn the $70 million verdict awarded to a gynecomastia plaintiff earlier this month. According to The Legal Intelligencer, Philadelphia Court of Common … Continue reading

Federal Essure Lawsuit Plaintiffs Petition for Multidistrict Litigation

Plaintiffs pursuing Essure birth control lawsuits in federal court have asked the U.S. Judicial Panel on Multidistrict Litigation (JPML) to centralize their cases in a single U.S. District Court for the purposes of coordinated pretrial proceedings. In a Motion filed … Continue reading

Invokamet Approved For Sale in Canada, Despite Ketoacidosis, Kidney Risks

Health Canada, the agency that regulates prescription drugs sold in that country, has approved Invokamet. The Type 2 diabetes medication was cleared for sale in Canada on July 20th, despite concerns about its potential association with ketoacidosis, kidney problems and … Continue reading

Study Questions Proton Pump Inhibitor Dosage for Women

A new study suggests that women with GERD would enjoy the same benefits from proton pump inhibitors even when prescribed lower doses of the drugs. Such an approach could reduce the risk of side effects that may occur when higher … Continue reading

Talcum Powder Lawsuit Blames Johnson & Johnson Products for Uterine Cancer

The litigation involving Johnson & Johnson’s talc-based powders continues to grow, with the recent filing of a uterine cancer lawsuit in California federal court. The plaintiff named in the complaint claims that her long-term use of Baby Powder and Shower-to-Shower … Continue reading

New Onglyza Lawsuit Filed On Behalf of Kentucky Heart Attack Victim

A Kentucky man and his wife have filed a new Onglyza lawsuit that accuses the drug’s manufacturer of failing to properly warn patients and doctors about its allege cardiovascular risks. According to the July 13th filing in the U.S. District … Continue reading

Follow Us

RXInjuryHelp.com on Google+  RXInjuryHelp.com on Facebook  RXInjuryHelp.com on LinkedIn  RXInjuryHelp.com on Twitter  RXInjuryHelp.com on YouTube  RXInjuryHelp.com on Pinterest

Skip to content